Correlation Between Duopharma Biotech and Hengyuan Refining

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Duopharma Biotech and Hengyuan Refining at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Duopharma Biotech and Hengyuan Refining into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Duopharma Biotech Bhd and Hengyuan Refining, you can compare the effects of market volatilities on Duopharma Biotech and Hengyuan Refining and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Duopharma Biotech with a short position of Hengyuan Refining. Check out your portfolio center. Please also check ongoing floating volatility patterns of Duopharma Biotech and Hengyuan Refining.

Diversification Opportunities for Duopharma Biotech and Hengyuan Refining

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Duopharma and Hengyuan is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Duopharma Biotech Bhd and Hengyuan Refining in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hengyuan Refining and Duopharma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Duopharma Biotech Bhd are associated (or correlated) with Hengyuan Refining. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hengyuan Refining has no effect on the direction of Duopharma Biotech i.e., Duopharma Biotech and Hengyuan Refining go up and down completely randomly.

Pair Corralation between Duopharma Biotech and Hengyuan Refining

Assuming the 90 days trading horizon Duopharma Biotech Bhd is expected to generate 0.62 times more return on investment than Hengyuan Refining. However, Duopharma Biotech Bhd is 1.61 times less risky than Hengyuan Refining. It trades about -0.19 of its potential returns per unit of risk. Hengyuan Refining is currently generating about -0.31 per unit of risk. If you would invest  131.00  in Duopharma Biotech Bhd on August 28, 2024 and sell it today you would lose (6.00) from holding Duopharma Biotech Bhd or give up 4.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Duopharma Biotech Bhd  vs.  Hengyuan Refining

 Performance 
       Timeline  
Duopharma Biotech Bhd 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Hengyuan Refining 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hengyuan Refining has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Hengyuan Refining is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

Duopharma Biotech and Hengyuan Refining Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Duopharma Biotech and Hengyuan Refining

The main advantage of trading using opposite Duopharma Biotech and Hengyuan Refining positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Duopharma Biotech position performs unexpectedly, Hengyuan Refining can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hengyuan Refining will offset losses from the drop in Hengyuan Refining's long position.
The idea behind Duopharma Biotech Bhd and Hengyuan Refining pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Technical Analysis
Check basic technical indicators and analysis based on most latest market data